227 related articles for article (PubMed ID: 22160464)
1. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization.
Chang EM; Han JE; Won HJ; Kim YS; Yoon TK; Lee WS
J Assist Reprod Genet; 2012 Mar; 29(3):225-30. PubMed ID: 22160464
[TBL] [Abstract][Full Text] [Related]
2. IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.
Ye H; Huang GN; Zeng PH; Pei L
J Assist Reprod Genet; 2009 Mar; 26(2-3):105-11. PubMed ID: 19225876
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.
Scheffer JB; Scheffer BB; Carvalho RF; Aguiar AP; Lozano DHM; Labrosse J; Grynberg M
JBRA Assist Reprod; 2019 Aug; 23(3):239-245. PubMed ID: 30875186
[TBL] [Abstract][Full Text] [Related]
4. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
5. Luteal estradiol pretreatment of poor and normal responders during GnRH antagonist protocol.
Sefrioui O; Madkour A; Kaarouch I; Louanjli N
Gynecol Endocrinol; 2019 Dec; 35(12):1067-1071. PubMed ID: 31142165
[TBL] [Abstract][Full Text] [Related]
6. Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of
Zhang C; Wu F; Wu Z; Sun B; Chen C; Qian W
Front Endocrinol (Lausanne); 2021; 12():739773. PubMed ID: 34707571
[TBL] [Abstract][Full Text] [Related]
7. Delayed Start Versus Conventional GnRH Antagonist Protocol in Poor Responders Pretreated With Estradiol in Luteal Phase: A Randomized Controlled Trial.
Maged AM; Nada AM; Abohamila F; Hashem AT; Mostafa WA; Elzayat AR
Reprod Sci; 2015 Dec; 22(12):1627-31. PubMed ID: 26045549
[TBL] [Abstract][Full Text] [Related]
8. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
Elassar A; Mann JS; Engmann L; Nulsen J; Benadiva C
Fertil Steril; 2011 Jan; 95(1):324-6. PubMed ID: 20797708
[TBL] [Abstract][Full Text] [Related]
9. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
10. Does the "delayed start" protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial.
Ashrafi M; Arabipoor A; Yahyaei A; Zolfaghari Z; Ghaffari F
Reprod Biol Endocrinol; 2018 Dec; 16(1):124. PubMed ID: 30593268
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the standard GnRH antagonist protocol and the luteal phase estradiol/GnRH antagonist priming protocol in poor ovarian responders.
Mutlu MF; Mutlu İ; Erdem M; Güler İ; Erdem A
Turk J Med Sci; 2017 Apr; 47(2):470-475. PubMed ID: 28425233
[TBL] [Abstract][Full Text] [Related]
12. Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.
Bildik G; Akin N; Seyhan A; Esmaeilian Y; Yakin K; Keles I; Balaban B; Ata B; Urman B; Oktem O
Hum Reprod; 2019 Feb; 34(2):345-355. PubMed ID: 30520979
[TBL] [Abstract][Full Text] [Related]
13. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
14. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.
Wei LH; Ma WH; Tang N; Wei JH
Taiwan J Obstet Gynecol; 2016 Feb; 55(1):50-4. PubMed ID: 26927248
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial.
Zhang Y; Liu L; Qin J; Huang H; Xue L; Wang S; Tan W
Reprod Biol Endocrinol; 2021 Oct; 19(1):158. PubMed ID: 34641897
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor-responding patients.
Davar R; Rahsepar M; Rahmani E
Arch Gynecol Obstet; 2013 Jan; 287(1):149-53. PubMed ID: 22923150
[TBL] [Abstract][Full Text] [Related]
18. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
[TBL] [Abstract][Full Text] [Related]
19. A luteal estradiol protocol for expected poor-responders improves embryo number and quality.
Frattarelli JL; Hill MJ; McWilliams GDE; Miller KA; Bergh PA; Scott RT
Fertil Steril; 2008 May; 89(5):1118-1122. PubMed ID: 17658529
[TBL] [Abstract][Full Text] [Related]
20. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
Olgan S; Humaidan P
Reprod Biol; 2017 Mar; 17(1):105-110. PubMed ID: 28173995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
